Adagene Inc.ADAGEarnings & Financial Report
Nasdaq · Health Care
Adagene Inc. is a global clinical-stage biotechnology company specializing in the research, development, and commercialization of innovative antibody-based cancer immunotherapies. Leveraging its proprietary next-generation antibody technology platforms, it develops targeted oncology treatments for patients across global markets, with core R&D bases in China and clinical programs covering North America, Asia, and Europe.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Peter Luo | 21.28% | 12.0M | — | 2024-03-01 |
| Panacea Venture Healthcare Fund I I, L.P. | 7.30% | 4.0M | ▲ +2.30pp | 2024-11-07 |
| FMR LLC | 6.41% | 3.4M | — | 2024-02-09 |